Evaluation of the new polyvinylacetate/ povidone excipient for matrix sustained release dosage forms

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Pharmazeutische Industrie

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Kollidon® SR: Formulation techniques and drug delivery applications.

  2024cites this paper
• Formulation of generic sustained release venlafaxine capsules

  2020cites this paper
• DEVELOPMENT AND EVALUATION OF VALSARTAN ORAL CONTROLLED RELEASE FORMULATIONS

  2018cites this paper
• Sustained release of diltiazem HCl tableted after co-spray drying and physical mixing with PVAc and PVP

  2016cites this paper
• Once-daily amoxicillin immediate- and extended-release bilayer tablets

  2016cites this paper
• Formulation of controlled-release pelubiprofen tablet using Kollidon(®) SR.

  2016cites this paper
• Development of Different Polymer Matrix Systems for Galantamine Hydrobromide Sustained Release

  2015cites this paper
• FABRICATION OF SUSTAINED RELEASE MATRIX TABLET FORMULATION OF METOPROLOL SUCCINATE USING PVAP

  2014cites this paper
• Design, characterization and in-vitro evaluation of different cellulosic acrylic and methacrylic polymers loaded aceclofenac microspheres.

  2014cites this paper
• FORMULATION, IN-VITRO AND IN-VIVO X-RAY EVALUATION OF KOLLIDON® SR MATRIX TABLETS OF DILTIAZEM HCL.

  2014cites this paper
• Use of hydrophilic and hydrophobic polymers for the development of controlled release tizanidine matrix tablets

  2014cites this paper
• Development and optimization of multiparticulate drug delivery system of alfuzosin hydrochloride.

  2013cites this paper
• Formulation optimization and evaluation of aceclofenac sustained release dosage form based on Kollidon sustained release

  2013cites this paper
• Formulation, Development and Evaluation of Timolol Maleate Sustained Release Matrix Tablets

  2012cites this paper
• Effect of Kollidon® SR on the release of Albuterol Sulphate from matrix tablets.

  2011cites this paper
• Formulation and Evaluation of Sustained-Release Matrix Tablets of Timolol Maleate.

  2011cites this paper
• STUDY OF EFFECTS OF POST­COMPRESSION CURING ON KOLLIDON ® SR BASED FLOATING TABLETS

  2011cites this paper
• Design and Evaluation of Metformin Hydrochloride Extended Release Tablets by Direct Compression

  2011cites this paper
• Formulation and Evaluation of Kollidon® SR for PH-Independent Extended Release Matrix Systems for Propranolol Hydrochloride

  2011cites this paper
• Development of pH-independent matrix type sustained release drug delivery system of propranolol hydrochloride

  2011cites this paper
• Effects of Thermal Curing Conditions on Drug Release from Polyvinyl Acetate–Polyvinyl Pyrrolidone Matrices

  2010cites this paper
• A flexible technology for modified-release drugs: multiple-unit pellet system (MUPS).

  2010cites this paper
• Preparation and In-vivo Pharmacokinetic Study of a Novel Extended Release Compression Coated Tablets of Fenoterol Hydrobromide

  2008cites this paper
• Characterization of poly(vinyl acetate) based floating matrix tablets.

  2008cites this paper
• New insights on poly(vinyl acetate)-based coated floating tablets: characterisation of hydration and CO2 generation by benchtop MRI and its relation to drug release and floating strength.

  2008cites this paper
• pH-independent drug release of an extremely poorly soluble weakly acidic drug from multiparticulate extended release formulations.

  2007cites this paper
• Effects of formulation and process variables on the release of a weakly basic drug from single unit extended release formulations.

  2006cites this paper
• Development of a single unit extended release formulation for ZK 811 752, a weakly basic drug.

  2005cites this paper
• Development of a multi particulate extended release formulation for ZK 811 752, a weakly basic drug.

  2005cites this paper
• Compressibility of floating pellets with verapamil hydrochloride coated with dispersion Kollicoat SR 30 D.

  2005cites this paper
• Development and evaluation of extended-release bumetanide tablets.

  2004influential citation